The present invention relates to biaryl-containing inverse agonists of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these biaryl- containing inverse agonists, and methods of modulating ROR-gamma receptors using these inverse agonists. Also provided are methods of using biaryl-containing inverse agonists to treat ROR-gamma mediated diseases.
本发明涉及含有
联苯基的ROR-gamma受体的逆激动剂。该发明还提供了包含这些含有
联苯基的逆激动剂的药物组合物,以及使用这些逆激动剂调节ROR-gamma受体的方法。同时提供了使用含有
联苯基的逆激动剂治疗ROR-gamma介导疾病的方法。